Targeting Liver Metastases in Uveal Melanoma: ATX-LPA Mediated Immunosuppression and Novel Therapeutic Approaches - Takeaways - MDSpire

Targeting Liver Metastases in Uveal Melanoma: ATX-LPA Mediated Immunosuppression and Novel Therapeutic Approaches

  • By

  • A. Turner, Jacqueline

  • D'Antonio, Marc

  • Montane, Heather

  • MacBeth, Morgan

  • Katsnelson, Elizabeth

  • Robinson, William

  • Tobin, Richard

  • Couts, Kasey L.

  • Markovic, Svetomir N

  • Torres, Raul M

  • May 29, 2026

  • 0 min

Share

  • 1

    Uveal melanoma shows a strong tendency to metastasize to the liver, where immune tolerance aids in disease progression.

  • 2

    Impaired CD8+ T cell immunosurveillance is a key factor in the progression of uveal melanoma.

  • 3

    The ATX-LPA axis is identified as a significant immunoregulatory pathway in the liver tumor microenvironment.

  • 4

    CD8+ T cells from hepatic metastasis exhibit significantly higher ATX transcripts compared to peripheral blood and healthy controls.

  • 5

    Genetic deletion of the LPA5 receptor on CD8+ T cells enhances their function during persistent antigen stimulation in the presence of LPA.

Original Source(s)

Related Content